Condition

Gastric Adenocarcinoma clinical trials and research

• 64Clinical trials
• 7NIH research projects
• 1New in 30 days
• 19Countries

Newest Gastric Adenocarcinoma clinical trials

All recruiting trials (64)

• 68Ga-YQ-CC05: a new probe for detecting tumors with CCK2R

  This study tests a radioactive probe called 68Ga-YQ-CC05 to see if it can safely help find tumors in adults with certain cancers using PET-CT imaging.

  Recruiting Nanjing First Hospital, Nanjing Medical University · Nanjing, Jiangsu · NCT07914764

• Neoadjuvant immunotherapy plus Nab-P-SOX for locally advanced gastric/GEJ cancer

  This phase 2, single-arm study tests a pre-surgery treatment that combines a PD-1/CTLA-4 bispecific antibody with nab-paclitaxel, oxaliplatin, and S-1 in adults with HER2-negative, locally advanced gastric or GEJ cancer.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07867392

• Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia

  This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.

  Recruiting at 4 sites Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. and 3 other locations · NCT07856212

• AI-powered tumor response assessment after preoperative treatment in stomach and gastroesophageal junction cancer

  Researchers are testing whether an AI tool called DeepTRG can reliably measure how much cancer remains in tissue removed after preoperative therapy in stomach and GEJ cancer, without needing a human to correct the AI results.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07849608

• Image-guided platform helps find sentinel lymph nodes in early gastric cancer

  This study tests whether an image-guided platform with a deep learning model can find and retrieve sentinel lymph nodes better than standard palpation in people with early gastric cancer undergoing LECS-SNNS.

  Recruiting Beijing Friendship Hospital · Beijing · NCT07835087

• Breath test to help detect gastrointestinal cancers early

  A breath test that looks for signals in exhaled air to see if someone with gut cancer symptoms might have oesophageal, stomach, pancreatic, liver, or colorectal cancer and need urgent testing.

  Recruiting Imperial College London · Maidstone, Kent and 5 other locations · NCT07714538

• Perioperative HLX10 (serplulimab) with SOX chemotherapy for PD-L1 positive gastric/GEJ cancer

  This study tests whether adding HLX10 (serplulimab) to the SOX chemotherapy before and after surgery helps people with PD-L1 positive, locally advanced gastric or GEJ cancer compared to SOX alone.

  Recruiting at 5 sites Phase 2 National Cancer Center, Japan · Chiba, Chiba and 17 other locations · NCT07699939

• A combination therapy with ASP2138 and standard chemotherapy plus pembrolizumab for advanced stomach and GEJ cancer

  This study tests ASP2138 along with pembrolizumab and chemotherapy to see if it helps people with advanced, inoperable, or metastatic gastric or GEJ cancer that is HER2-negative and CLDN18.2-positive.

  Recruiting at 12 sites Phase 3 Astellas Pharma Inc · Saint Louis Park, Minnesota and 11 other locations · NCT07673887

• HIPEC-primed therapy with serplulimab plus SOX/XELOX for locally advanced gastric cancer

  This study tests a HIPEC-priming approach followed by PD-1 blocker–based chemotherapy to see if it helps people with locally advanced gastric cancer who have not yet spread.

  Recruiting Phase 2 Shanghai Changzheng Hospital · Shanghai · NCT07621484

• Personalized ultrafractionated radiation plus immunotherapy for unresectable stomach cancer

  This study tests, in patients with unresectable locally advanced stomach cancer who have not progressed after initial therapy, whether adding PULSAR radiation to ongoing systemic treatment improves control of the tumor.

  Recruiting Samsung Medical Center · Seoul, Select Province/State · NCT07607119

• JS107 plus toripalimab and chemotherapy as first-line treatment for CLDN18.2-positive gastric cancer

  This trial tests whether JS107 added to toripalimab and XELOX is better than a similar regimen with sintilimab for patients with untreated, CLDN18.2-positive, HER2-negative advanced gastric or GEJ adenocarcinoma.

  Recruiting Phase 3 NingBo Junyan Hongshi Biosciences Co., Ltd · Guangzhou, Guangdong · NCT07584135

• Olanzapine added to chemotherapy for gastric cancer to help keep weight and appetite up

  This study tests whether adding low-dose olanzapine to standard neoadjuvant chemotherapy helps patients with gastric cancer maintain weight and appetite during treatment.

  Recruiting Phase 2 University of Illinois Chicago · Chicago, Illinois · NCT07581405

• DISP-10 for advanced colorectal, gastric, and esophageal cancers

  This trial will test a one-time combination of an engineered adenovirus (DV-10) and BCMA-directed CAR T cells (ide-cel) in adults with advanced colorectal, gastric, or esophageal cancers.

  Recruiting at 6 sites Phase 1 Dispatch Biotherapeutics · Duarte, California and 6 other locations · NCT07544589

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• Gastric Precancerous Epithelial Pathway in India Using High-Definition Endoscopy

  This study tests how common early gastric cancer is among adults 40 and older undergoing endoscopy in India.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT07486518

• Shr-1701 with or without Apatinib plus chemotherapy as neoadjuvant treatment for gastric cancer

  This trial tests whether adding SHR-1701, with or without apatinib, to chemotherapy before surgery helps patients with resectable locally advanced gastric or gastroesophageal junction cancer.

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07464756

• AVA6103 for advanced or metastatic FAP-positive solid tumors

  This study will test whether the experimental IV drug AVA6103 is safe and can help adults with advanced or metastatic FAP-positive cancers such as pancreatic, gastric/GEJ, cervical, or vulvar adenocarcinomas.

  Recruiting at 7 sites Phase 1 Avacta Life Sciences Ltd · Scottsdale, Arizona and 6 other locations · NCT07454642

• Adherence to a Remote Physical Activity Program on a Smartwatch and its Effect on Fatigue After Adjuvant Chemotherapy

  This study tests whether sticking with an adapted physical activity program tracked on a smartwatch can reduce fatigue in adults who have finished adjuvant chemotherapy for certain cancers.

  Recruiting Centre Antoine Lacassagne · Nice · NCT07429487

• Zolbetuximab with chemotherapy for HER2-negative, Claudin 18.2–positive metastatic gastric or gastroesophageal junction adenocarcinoma

  This project will try zolbetuximab together with FOLFOX or XELOX as first-line treatment for adults whose HER2-negative stomach or gastroesophageal junction cancers strongly express Claudin 18.2.

  Recruiting European Institute of Oncology · Milan · NCT07427992

• Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer

  This trial will try fruquintinib together with trastuzumab and XELOX to see if it helps people with HER2‑positive advanced stomach or gastroesophageal junction cancer as their first treatment.

  Recruiting Phase 1/2 Henan Cancer Hospital · Zhengzhou, Henan · NCT07334431

• PLX-61639 for advanced SMARCA4-deficient solid tumors

  This trial will test a daily oral drug called PLX-61639 in people with advanced or metastatic solid tumors that have a SMARCA4 loss and who have no other approved treatment options.

  Recruiting at 10 sites Phase 1 Plexium, Inc. · Scottsdale, Arizona and 9 other locations · NCT07284186

• Planned surgery or focused local treatment after chemo for metastatic upper-GI adenocarcinoma with undetectable ctDNA

  This test sees if adding planned surgery or local treatments after three months of chemotherapy helps people with metastatic upper-gastrointestinal adenocarcinomas who have undetectable ctDNA.

  Recruiting Phase 2 Yale University · New Haven, Connecticut · NCT07282912

• IDE892 alone and with IDE397 for MTAP-deleted advanced solid tumors

  This trial tests IDE892 by itself and combined with IDE397 in adults whose advanced solid tumors have MTAP deletion and have progressed after standard treatments.

  Recruiting at 23 sites Phase 1 IDEAYA Biosciences · Goodyear, Arizona and 22 other locations · NCT07277413

• Sintilimab added to SOX chemotherapy after surgery for PD-L1–positive pN3 gastric cancer

  This trial will test whether adding the PD-1 blocker sintilimab to standard SOX chemotherapy after surgery helps people with PD-L1–positive, pathologic N3 gastric cancer stay cancer-free longer.

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07263386

• NRM-823 for advanced or metastatic refractory solid tumors

  This trial tests whether NRM-823 is safe and can help people with advanced or metastatic head and neck, esophageal, gastric, or related cancers.

  Recruiting at 18 sites Phase 1 Normunity AccelCo, Inc. · Denver, Colorado and 17 other locations · NCT07182149

• Cytoreductive surgery plus heated intraperitoneal chemotherapy for gastric cancer with peritoneal-only spread

  This study will try cytoreductive surgery combined with heated intraperitoneal chemotherapy, together with preoperative chemotherapy and laparoscopic HIPEC, in adults whose gastric adenocarcinoma is limited to the peritoneum or shows positive peritoneal cytology.

  Recruiting Phase 2 Banner Health · Gilbert, Arizona · NCT07178808

• BL-M07D1 versus chemotherapy for HER2-positive advanced gastric or gastroesophageal junction cancer

  This trial tests whether BL-M07D1 works better than a doctor's choice of chemotherapy for adults with HER2‑positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma after first‑line anti‑HER2 therapy has failed.

  Recruiting at 2 sites Phase 3 Sichuan Baili Pharmaceutical Co., Ltd. · Harbin, Heilongjiang and 1 other locations · NCT07152405

• Randomized Phase III treatment for CLDN18.2-positive unresectable locally advanced or metastatic gastric cancer

  This trial will try IMC002 CAR T-cell therapy versus the doctor's choice of treatment for adults with CLDN18.2-positive unresectable locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma who have had at least two prior treatments.

  Recruiting Phase 3 Suzhou Immunofoco Biotechnology Co., Ltd · Beijing · NCT07103668

• Tislelizumab plus FLOT given before surgery for operable esophagus or stomach adenocarcinoma

  This trial tests whether adding the immunotherapy drug tislelizumab to FLOT chemotherapy given before surgery helps people with locally advanced, resectable esophagus or stomach adenocarcinoma shrink tumors and better tolerate treatment.

  Recruiting at 2 sites Phase 1 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Frankfurt and 3 other locations · NCT07059299

• MRD-guided postoperative treatment for locally advanced gastric cancer

  This trial will test whether using MRD results from peritoneal lavage fluid to decide on adding intraperitoneal chemotherapy after surgery can lower peritoneal relapse in people with locally advanced gastric cancer.

  Recruiting Early Phase 1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT07034742

• Enhanced recovery after laparoscopic distal gastrectomy without routine abdominal drainage tubes

  This trial will test whether skipping routine abdominal drainage tubes during enhanced recovery after laparoscopic distal gastrectomy helps adults (18–80) with gastric adenocarcinoma recover as well as using drains.

  Recruiting at 6 sites Phase 3 Lanzhou University Second Hospital · Beijing, Beijing Municipality and 5 other locations · NCT07029269

• Conversion therapy with surgery and targeted para‑aortic radiotherapy for gastric cancer with retroperitoneal (station 16) lymph node spread

  This trial tests whether chemotherapy (SOX with or without a PD‑1 inhibitor), followed by D2 gastrectomy and para‑aortic radiotherapy, helps people with gastric adenocarcinoma who have only para‑aortic lymph node metastases live longer without their cancer progressing compared with standard chemotherapy alone.

  Recruiting Phase 2 Shandong Cancer Hospital and Institute · Jinan, Shandong · NCT07007182

• Adding paclitaxel into the abdominal cavity for gastric cancer that has spread to the peritoneum

  This trial will try adding paclitaxel delivered directly into the abdomen to standard IV chemotherapy for people with gastric or gastroesophageal junction cancer that has spread to the lining of the abdominal cavity to see if it slows disease growth and helps them live longer.

  Recruiting at 78 sites Phase 2/3 Eastern Cooperative Oncology Group · Irvine, California and 77 other locations · NCT07001748

• Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors

  This trial will try a single direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal tumors to see if it is safe for adults with advanced metastatic gastrointestinal or peritoneal cancers who have not responded to standard treatments.

  Recruiting Phase 1 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07001592

• Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer

  This trial will test whether giving local treatment (surgery or radiation) earlier or later after first-line systemic therapy works better for people whose esophageal or stomach cancer has spread to only a few sites.

  Recruiting at 4 sites Phase 2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam and 4 other locations · NCT07000253

• Combining Adebrelimab with Chemoradiotherapy and Surgery for Gastric Cancer

  This study is testing if adding a new immunotherapy drug called Adebrelimab to standard treatments for stomach cancer can help patients with advanced cases do better and have a better chance of recovery.

  Recruiting Phase 2 Jiangsu Cancer Institute & Hospital · Nanjing, Province · NCT06985602

• Gastric cancer screening using stool H. pylori high-risk gene testing and a risk questionnaire

  We are testing whether a stool H. pylori genetic risk test plus a short risk questionnaire can find gastric cancer earlier in adults aged 40 and older.

  Recruiting Fudan University · Tongling · NCT06943781

• Robotic surgery for advanced gastric cancer

  This study is testing if robotic surgery can safely help people with advanced stomach cancer by reducing blood loss and hospital stays compared to traditional methods.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT06881043

• Combination treatment for advanced gastric and gastro-esophageal junction cancer

  This study is testing a new combination treatment for people with advanced stomach cancer to see if it helps them before and after surgery.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT06808971

• Combining Sintilimab with Chemotherapy for Stage III Gastric Cancer Treatment

  This study is testing if combining a new drug called Sintilimab with chemotherapy can help people with stage III gastric cancer feel better after their surgery.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality · NCT06761846

• Assessing lymph node removal quality during minimally invasive gastric cancer surgery

  This study is testing a new scoring system to see if it can help doctors better assess lymph node removal during minimally invasive surgery for stomach cancer and improve patient outcomes.

  Recruiting at 7 sites Azienda Ospedaliero-Universitaria di Parma · Cremona, CR and 7 other locations · NCT06466902

• Reducing dosing frequency of immune checkpoint inhibitors in advanced cancers

  This study is testing if giving immune checkpoint inhibitors less often can still help people with advanced cancers feel better while making treatment easier and cheaper.

  Recruiting Phase 2 National University Hospital, Singapore · Singapore · NCT06422403

• Collecting health information to understand and prevent gastric cancer

  This study is trying to gather health information from people with early signs of gastric cancer, as well as healthy individuals and those already diagnosed, to better understand what might lead to this type of cancer.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06370143

• Combination of OBP-301 and Pembrolizumab for Advanced Esophagogastric Cancer

  This study is trying a new treatment combining OBP-301 and pembrolizumab to see if it can help people with advanced esophageal and gastric cancer who haven't responded well to previous immunotherapy.

  Recruiting at 2 sites Phase 2 Weill Medical College of Cornell University · New York, New York and 1 other locations · NCT06340711

• Dostarlimab treatment for advanced or metastatic cancers with specific genetic markers

  This study is testing if the immunotherapy dostarlimab can help people with certain advanced cancers that have specific genetic markers feel better compared to standard chemotherapy.

  Recruiting Phase 2 Unicancer · Angers and 21 other locations · NCT06333314

• Assessing biomarkers after surgery for oesophagogastric cancer

  This study is trying to find out if certain biological markers in patients who had surgery for oesophageal and gastric cancer can help predict how well they will respond to treatment and their chances of recovery.

  Recruiting Imperial College London · London · NCT06289374

• Combination treatment for advanced gastric and gastroesophageal junction cancer

  This study is testing a new combination of two medications with chemotherapy to see if it can help adults with advanced stomach or gastroesophageal junction cancer.

  Recruiting Phase 2 Harbin Medical University · Harbin · NCT06196697

• Combining pembrolizumab, trastuzumab, and chemotherapy for HER2+ esophagogastric cancer

  This study is testing if adding pembrolizumab and trastuzumab to standard chemotherapy can help people with resectable HER2+ esophagogastric cancer do better in their treatment.

  Recruiting at 9 sites Phase 2 Memorial Sloan Kettering Cancer Center · Boston, Massachusetts and 9 other locations · NCT06123338

• Using dostarlimab to avoid surgery in localized gastric cancer

  This study is testing if the drug dostarlimab can help patients with certain types of stomach cancer avoid surgery by seeing if their cancer completely responds to treatment.

  Recruiting at 17 sites Phase 2 GERCOR - Multidisciplinary Oncology Cooperative Group · Besançon and 17 other locations · NCT06059495

• Combining TRK-950 with Ramucirumab and Paclitaxel for Gastric Cancer

  This study is testing if adding a new drug called TRK-950 to the standard treatments ramucirumab and paclitaxel can help people with gastric cancer live longer and feel better.

  Recruiting at 27 sites Phase 2 Toray Industries, Inc · Duarte, California and 26 other locations · NCT06038578

• Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer

  This study is testing two different chemotherapy plans for people with advanced stomach cancer to see which one helps them better tolerate treatment and successfully have surgery.

  Recruiting at 2 sites Phase 2/3 Ukrainian Society of Clinical Oncology · Vilnius and 1 other locations · NCT06028737

• Using paclitaxel and surgery to improve outcomes in gastric cancer patients

  This study is testing if giving a chemotherapy drug called paclitaxel along with surgery can help people with advanced gastric cancer live longer and feel better.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT05977998

• Long-term outcomes of endoscopic procedures for upper gastrointestinal cancers

  This study looks at how well certain endoscopic procedures work for treating larger upper gastrointestinal cancers and what the long-term results are for patients.

  Recruiting Western Sydney Local Health District · Sydney, New South Wales · NCT05804331

• Robotic surgery and heated chemotherapy for gastric cancer with peritoneal spread

  This study is testing if a new robotic surgery combined with heated chemotherapy can help people with advanced stomach cancer that has spread to the abdominal lining feel better and live longer.

  Recruiting Phase 2 Mayo Clinic · Rochester, Minnesota · NCT05753306

• Assessing nutritional status in gastric cancer patients using bioelectrical impedance analysis

  This study is testing if a special method can help doctors check the nutrition and body health of gastric cancer patients during their treatment to better support their care.

  Recruiting Medical University of Lublin · Lublin · NCT05723718

• Testing ASP2138 for stomach and pancreatic cancer treatment

  This study is testing a new drug called ASP2138 to see if it can help adults with stomach or pancreatic cancer by boosting their immune response when used alone or with standard treatments.

  Recruiting at 42 sites Phase 1 Astellas Pharma Inc · Orange, California and 45 other locations · NCT05365581

• Combining chemotherapy and immunotherapy for advanced esophagogastric cancer

  This study is testing a new treatment plan that combines two chemotherapy drugs with an immunotherapy to see if it helps people with advanced esophagogastric cancer feel better and live longer.

  Recruiting at 5 sites Phase 2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam and 7 other locations · NCT05177133

• Observing cancer recurrence using a blood test

  This study is testing a new blood test to see if it can help find out if cancer comes back in people who have been treated for early-stage solid tumors.

  Recruiting at 49 sites Guardant Health, Inc. · Birmingham, Alabama and 56 other locations · NCT05059444

• Evaluating the impact of tumor microenvironment on treatment outcomes in advanced gastric cancer

  This study is trying to see how the environment around tumors in patients with advanced stomach cancer affects how well their treatment works.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT04850729

• Registry for gastric and esophageal cancer treatments in Germany

  This study is collecting information on how patients in Germany with advanced esophageal and stomach cancers are treated to see how well different treatments work in real life.

  Recruiting iOMEDICO AG · Multiple Locations · NCT04290806

• Combination of chemotherapy and immunotherapy for advanced esophageal and gastric cancer

  This study is testing a new combination of chemotherapy and immunotherapy to see if it helps people with advanced esophageal and gastric cancer feel better and have fewer side effects than current treatments.

  Recruiting Phase 2 University of Wisconsin, Madison · Madison, Wisconsin · NCT04150640

• Combining Anti-PD-1 Therapy with Metformin and Rosiglitazone for Cancer Treatment

  This study is testing if combining a cancer treatment called anti-PD-1 therapy with two diabetes medications, Metformin and Rosiglitazone, can help people with advanced solid tumors fight their cancer better.

  Recruiting Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT04114136

• Combining Paclitaxel, Oxaliplatin, and S-1 for treating advanced gastric cancer

  This study is testing a new combination of three drugs to see if it can help people with advanced stomach cancer become healthy enough for surgery.

  Recruiting Peking University Cancer Hospital & Institute · Beijing, Beijing Municipality · NCT04047953

• Chemotherapy with or without radiation or surgery for oligometastatic esophageal or gastric cancer

  This study is testing if adding radiation or surgery to chemotherapy helps people with oligometastatic esophageal or gastric cancer live longer and feel better.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT03161522

NIH-funded research (7)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Understanding how CDH1 loss drives aggressive stomach cancer and how to target it

  Researchers are studying why certain advanced stomach cancers grow and spread, with a focus on CDH1 inactivation and related pathways to find ways to improve treatment for patients.

  NIH research Louisiana State Univ Hsc Shreveport · Shreveport, United States · NIH-11512968

• Common stem cell origin in Barrett's-related cancers

  This research looks at whether a single stem cell type drives both esophageal and gastric cancers that arise from Barrett’s esophagus, with the aim of finding shared clues to prevent or treat these diseases.

  NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11416592

• Shared stem cell source for lower esophagus and upper stomach cancers

  This project looks at whether the same type of stem cell drives cancers that start in Barrett's esophagus and the nearby stomach, with implications for people who have Barrett's esophagus or gastric intestinal metaplasia.

  NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11399448

• Targeting YAP1 to stop stomach cancer spread and immune suppression

  This project looks for ways to block a protein called YAP1 to help people with advanced stomach (gastric) cancer that has spread to the lining of the abdomen.

  NIH research Coriell Institute for Medical Research · Camden, United States · NIH-11167443

• Understanding how certain genetic changes lead to advanced stomach cancer

  This study is looking into how a specific gene called CDH1 affects the growth of advanced stomach cancer, with the hope of finding better treatment options tailored to different types of the disease, so that patients can receive care that works best for them.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11052790

• Understanding and targeting cancer stemness and immune suppression in advanced gastric cancer

  This study is looking at how a protein called YAP1 affects advanced stomach cancer, especially in patients with cancer that has spread to the lining of the abdomen, to find new ways to treat this tough condition and help improve outcomes for patients.

  NIH research Coriell Institute for Medical Research · Camden, United States · NIH-10933008

• Investigating the common origin of esophageal and gastric cancers

  This study is looking into how esophageal adenocarcinoma and intestinal gastric cancer start and develop, aiming to find early warning signs and better treatments for people dealing with these cancers.

  NIH research University of Houston · Houston, United States · NIH-10925194

Related topics

Quick answers

How many Gastric Adenocarcinoma clinical trials are recruiting right now?

64, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in China (24 trials), United States (23 trials), France (5 trials), Italy (5 trials), Japan (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 26, Phase 1: 8, Phase 3: 5, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →